AXON Dx

AXON Dx is a private life sciences diagnostics company developing fluorescence imaging systems and associated reagents for rare-cell detection, with an emphasis on circulating tumor cells from blood samples. Its core nCyte platform combines optical imaging, automated slide scanning, and AI-assisted image analysis to detect and characterize rare cells in research and translational oncology workflows. The company positions its products as compact, lower-cost tools that can support decentralized or point-of-care style cancer-testing workflows, although current website materials state the products are for research use only and not for diagnostic procedures. AXON Dx also offers analytical reagents and custom assay support for circulating epithelial, endothelial, and stromal cell applications. The business appears to follow an instrument-plus-consumables model centered on nCyte systems and related kits.